ArticleHuman molecular genetics2026
Modification of internal RNA domains from the long non-coding RNA XIST refines roles in silencing and heterochromatin recruitment.
Article in Human molecular genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
XIST is a paradigmatic long non-coding RNA required for the initiation of the epigenetic silencing of X chromosomes, leading to dosage compensation in mammalian females. XIST includes tandem repeat domains (A-F) that serve as binding platforms for protein complexes involved in silencing, localization, and heterochromatinization of the inactive X chromosome. XIST/Xist transgenes can silence autosomes as well as the X in both early development and somatic cells. In our quest to create a minimal but highly functional XIST transgene, we have tested both removal of non-repeat regions of XIST and duplication of repeat regions previously established as critical for XIST function. Targeting inducible XIST transgenes to an autosomal FRT site in somatic cells allows us to compare the activity of induced constructs on silencing and chromatin recruitment. We have previously identified that the CCC-dense mouse polycomb-interaction domain (PID) could restore functionality to a minimal human XIST construct lacking the B and D repeats. We now demonstrate that the density of the CCC motifs is not the sole contributor to PID functionality in the human transgene. Surprisingly, a duplication of repeat A reduces the expression from the exogenous promoter, as does removal of the region around the F repeats including six YY1 binding sites. In this context of an inducible XIST in somatic cells the internal small exons were not required; however, duplication of the E repeat region augmented functionality. Overall, the strongest correlations we observed across our diverse set of constructs were between chromatin deposition and silencing.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.